Following a horrific epidemic in West Africa that claimed the lives of over 11,000 people — the deadliest the world had ever seen — we finally have a breakthrough vaccine against Ebola. As Vox.com reported:
Today, the same researchers — who hail from the World Health Organization, Guinea’s Ministry of Health, Public Health England, and other international partners — have unveiled their final results in the Lancet, and they’re just as remarkable. The vaccine was tested in a trial involving nearly 12,000 people in Guinea and Sierra Leone during 2015 and 2016. Among the 5,837 people who got the vaccine, no Ebola cases were recorded. By comparison, there were 23 Ebola cases in the control group that had not gotten the vaccine.
“This trial, confirming the 100 percent efficacy of the rVSV Ebola vaccine, is a simply remarkable outcome”, Dr. Jeremy Farrar, the director of the Wellcome Trust, said of the research. “We’ve shown that by working collaboratively, across international borders and sectors, we can develop and test vaccines rapidly and use them to help bring epidemics to an end”.
You can read the published study here. It was one of fifteen clinical trials for an Ebola vaccine conducted around the world in a single year, and is a vindication of what collective action and responsibility by the international community — including the U.N., NGOs, and national governments — can accomplish. It is a shame it took so many deaths spanning a nearly three year period to finally come up with a promising form of prevention, although the vaccine is far from ready to hit the market. Continue reading